Zylox-Tonbridge Medical Technology Co., Ltd. Stock price
Equities
2190
CNE100004JD2
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.69 HKD | 0.00% | +1.79% | -22.11% |
Mar. 22 | Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 | MT |
Mar. 21 | Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2023 | 528M 73.02M 571M | Sales 2024 * | 756M 105M 819M | Capitalization | 2.93B 406M 3.17B |
---|---|---|---|---|---|
Net income 2023 | -78M -10.79M -84.44M | Net income 2024 * | 72M 9.96M 77.94M | EV / Sales 2023 | 7.02 x |
Net cash position 2023 * | 1.05B 145M 1.13B | Net cash position 2024 * | 994M 138M 1.08B | EV / Sales 2024 * | 2.56 x |
P/E ratio 2023 |
-47.1
x | P/E ratio 2024 * |
40.7
x | Employees | 765 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 32.23% |
1 week | +1.79% | ||
Current month | +4.64% | ||
1 month | -0.51% | ||
3 months | -21.47% | ||
6 months | +19.93% | ||
Current year | -22.11% |
Managers | Title | Age | Since |
---|---|---|---|
Zhong Zhao
CEO | Chief Executive Officer | 58 | 12-11-05 |
Quan Wei Yuan
DFI | Director of Finance/CFO | 46 | 20-12-31 |
Ning Pan
CTO | Chief Tech/Sci/R&D Officer | 58 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Ze Liang
BRD | Director/Board Member | 53 | 21-03-01 |
Hui Wang
BRD | Director/Board Member | 52 | 15-10-31 |
Da Song Wang
BRD | Director/Board Member | 56 | 20-10-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 9.69 | 0.00% | 201 000 |
24-03-27 | 9.69 | +0.31% | 207,000 |
24-03-26 | 9.66 | -0.41% | 174,500 |
24-03-25 | 9.7 | +0.52% | 268,500 |
24-03-22 | 9.65 | +1.37% | 622,629 |
Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.11% | 406M | |
+19.35% | 136B | |
-6.95% | 11.49B | |
+15.53% | 10.12B | |
+7.16% | 6.47B | |
+10.72% | 3.51B | |
+11.12% | 3.43B | |
-11.59% | 2.08B | |
-10.32% | 2B | |
-27.94% | 1.68B |